Biopharmaceuticals
FDA
News Release - June 4, 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Source: AstraZeneca
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.